tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX

Compare Lineage Therap (LCTX) vs. Competitors

2,046 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lineage Therap
$1.57
$391.07M
-6.05
259.27%
3 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$14.74
$306.75M
-1,186.14
70.60%
0 Buy
0 Hold
1 Sell
Moderate Sell
Tvardi Therapeutics
$3.02
$28.33M
-1.75
-80.26%
4 Buy
3 Hold
0 Sell
Moderate Buy
DBV Technologies SA - American
$21.06
$1.16B
-3.63
173.51%
5 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$9.48
$483.97M
-3.10
189.02%
7 Buy
2 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$6.54
$419.54M
-3.10
10.10%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LCTX
Lineage Therap
1.57
1.17
292.50%
AMRN
Amarin
14.74
6.58
80.64%
TVRD
Tvardi Therapeutics
3.02
-11.23
-78.81%
DBVT
DBV Technologies SA - American
21.06
13.62
183.06%
FDMT
4D Molecular Therapeutics
9.48
6.83
257.74%
AURA
Aura Biosciences Inc
6.54
1.02
18.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts